Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion type Assertion NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_head.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion description "[COMT haplotypes may serve as genetic predictors of propranolol treatment outcome, identifying a subgroup of TMD patients who will benefit from propranolol therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_provenance.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion evidence source_evidence_literature NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_provenance.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion SIO_000772 20216107 NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_provenance.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion wasDerivedFrom gad-20150221 NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_provenance.
- NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_assertion wasGeneratedBy ECO_0000203 NP113919.RA_uagh6zGbi-NGoT1xi2_5JDN26ZhFSLg2mF3c8j7BNA130_provenance.